Cost-effectiveness of modified fully oral 9-month treatment regimens for rifampicin-resistant tuberculosis in Belarus, Georgia, Kazakhstan and the Republic of Moldova

IntroductionPrior to 2020, treatment options for multidrug-resistant tuberculosis (MDR-TB) were limited and typically involved long treatment durations and high financial burdens. In the eastern European and central Asian (EECA) region, traditional inpatient tuberculosis (TB) care models, alongside...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	BMJ global health Ročník 10; číslo 11; s. e018099
Hlavní autoři:	Allel, Kasim, Palmer, Tom, Abou Jaoude, Gerard Joseph, Korotych, Oleksandr, Yedilbayev, Askar, Vilc, Valentina, Corloteanu, Andrei, Macari, Mariana, Evghenia, Cula, Laticevschi, Dumitru, Shakhimurat-Shaimovich, Ismailov, Anar-Saduakasovna, Rakisheva, Gulzhan-Elbrusovna, Tulepova, Anatolievna-Ryazanet, Daria, Shahrizada-Yergalymovna, Aimbekova, Yatskevich, Natalia, Skrahina, Alena, Zhurkin, Dmitry, Avaliani, Zaza, Kiria, Nana, Lomtadze, Nino, Kiria, Nino, Avaliani, Teona, Khonelidze, Irma, Danelia, Maka, Maxim, Corina, Haghparast-Bidgoli, Hassan, Skordis, Jolene
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	England BMJ Publishing Group Ltd 08.11.2025 BMJ Publishing Group
Témata:	Administration, Oral Adult Antitubercular Agents - administration & dosage Antitubercular Agents - economics Antitubercular Agents - therapeutic use Cost-Benefit Analysis Female Georgia (Republic) Health economics Humans Kazakhstan Male Middle Aged Moldova Original research Quality-Adjusted Life Years Republic of Belarus Rifampin - administration & dosage Rifampin - therapeutic use Tuberculosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - economics Republic of Belarus Moldova Georgia (Republic) Kazakhstan Health economics Tuberculosis
ISSN:	2059-7908, 2059-7908
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!